{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:27Z","timestamp":1753891227160,"version":"3.41.2"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>We present the case of a female patient with a heterozygous somatic BLNK mutation, a T-cell LGL (large granular lymphocyte) leukemia, and multiple autoimmune diseases. Although this mutation seems uncommon especially in this kind of clinical observation, it could represent a new mechanism for autoimmune diseases associated with LGL leukemia. The patient developed several autoimmune diseases: pure red blood cell apalsia, thyroiditis, oophoritis, and alopecia areata. She also presented a T-cell LGL leukemia which required treatment with corticosteroids and cyclophosphamide, with good efficacy. Interestingly, she had no notable infectious history. The erythroblastopenia also resolved, the alopecia evolves by flare-ups, and the patient is still under hormonal supplementation for thyroiditis and oophoritis. We wanted to try to understand the unusual clinical picture presented by this patient. We therefore performed whole-genome sequencing, identifying a heterozygous somatic BLNK mutation. Her total gamma globulin level was slightly decreased. Regarding the lymphocyte subpopulations, she presented a B-cell deficiency with increased autoreactive B-cells and a CD4+ and Treg deficiency. This B-cell deficiency persisted after complete remission of erythroblastopenia and LGL leukemia. We propose that the persistent B-cell deficiency linked to the BLNK mutation can explain her clinical phenotype.<\/jats:p>","DOI":"10.3389\/fmed.2022.997161","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T05:18:18Z","timestamp":1668575898000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["BLNK mutation associated with T-cell LGL leukemia and autoimmune diseases: Case report in hematology"],"prefix":"10.3389","volume":"9","author":[{"given":"Guillemette","family":"Fouquet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Ricard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Guillem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucile","family":"Couronn\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Asnafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon","family":"Vavasseur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Parisot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Garcelon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Rieux-Laucat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ars\u00e8ne","family":"Mekinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","article-title":"LGL leukemia: from pathogenesis to treatment","volume":"129","author":"Lamy","year":"2017","journal-title":"Blood."},{"key":"B2","doi-asserted-by":"publisher","first-page":"61876","DOI":"10.18632\/oncotarget.18711","article-title":"STAT3 mutation impacts biological and clinical features of T-LGL leukemia","volume":"8","author":"Teramo","year":"2017","journal-title":"Oncotarget."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.3390\/cancers12123508","article-title":"STAT3 and STAT5B mutations in T\/NK-cell chronic lymphoproliferative disorders of large granular lymphocytes (LGL): association with disease features","volume":"12","author":"Mu\u00f1oz-Garc\u00eda","year":"2020","journal-title":"Cancers."},{"key":"B4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.beha.2019.06.003","article-title":"Genomics of LGL leukemia and select other rare leukemia\/lymphomas","volume":"32","author":"Moosic","year":"2019","journal-title":"Best Pract Res Clin Haematol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1182\/blood.2021013164","article-title":"Genomic landscape of TCR\u03b1\u03b2 and TCR\u03b3\u03b4 T-large granular lymphocyte leukemia","volume":"139","author":"Cheon","year":"2022","journal-title":"Blood."},{"key":"B6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.seminhematol.2022.07.004","article-title":"The spectrum of somatic mutations in large granular lymphocyte leukemia, rheumatoid arthritis, and Felty's syndrome","volume":"59","author":"Savola","year":"2022","journal-title":"Semin Hematol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1182\/blood-2009-09-243071","article-title":"Complement receptor 2\/CD21- human naive B-cells contain mostly autoreactive unresponsive clones","volume":"115","author":"Isnardi","year":"2010","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1172\/JCI85113","article-title":"Human regulatory B-cells in health and disease: therapeutic potential","volume":"127","author":"Mauri","year":"2017","journal-title":"J Clin Invest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1056\/NEJMoa040036","article-title":"Autoimmune lymphoproliferative syndrome with somatic Fas mutations","volume":"351","author":"Holzelova","year":"2004","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jbi.2018.02.019","article-title":"A clinician friendly data warehouse oriented toward narrative reports: Dr","volume":"80","author":"Garcelon","year":"2018","journal-title":"Warehouse J Biomed Inform."},{"key":"B11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.immunol.021908.132649","article-title":"Primary B-cell immunodeficiencies: comparisons and contrasts","volume":"27","author":"Conley","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jaci.2013.01.044","article-title":"B-cell linker protein expression contributes to controlling allergic and autoimmune diseases by mediating IL-10 production in regulatory B-cells","volume":"131","author":"Jin","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jaci.2013.12.1083","article-title":"The BLNK adaptor protein has a non-redundant role in human B-cell differentiation","volume":"134","author":"Lagresle-Peyrou","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s10875-015-0164-2","article-title":"Enteroviral infection in a patient with BLNK adaptor protein deficiency","volume":"35","author":"NaserEddin","year":"2015","journal-title":"J Clin Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1126\/science.286.5446.1954","article-title":"An essential role for BLNK in human B-cell development","volume":"286","author":"Minegishi","year":"1999","journal-title":"Science."},{"key":"B16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ajhg.2007.10.011","article-title":"Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements","volume":"82","author":"van Zelm","year":"2008","journal-title":"Am J Hum Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"103019","DOI":"10.1016\/j.msard.2021.103019","article-title":"Peripheral blood B-cell subset ratios and expression levels of B-cell-associated genes are altered in benign multiple sclerosis","volume":"52","author":"Turkoglu","year":"2021","journal-title":"Mult Scler Relat Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/imcb.12552","article-title":"Peripheral B-cell dysregulation is associated with relapse after long-term quiescence in patients with multiple sclerosis","volume":"100","author":"Marsh-Wakefield","year":"2022","journal-title":"Immunol Cell Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jaut.2012.09.001","article-title":"Rheumatoid arthritis is associated with signaling alterations in naturally occurring autoreactive B-lymphocytes","volume":"40","author":"Liubchenko","year":"2013","journal-title":"J Autoimmun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/s41590-022-01271-6","article-title":"Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet(+) B-cells","volume":"23","author":"Csomos","year":"2022","journal-title":"Nat Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1182\/blood-2013-03-491464","article-title":"Long-term remission of T-cell large granular lymphocyte leukemia associated with rheumatoid arthritis after rituximab therapy","volume":"122","author":"Cornec","year":"2013","journal-title":"Blood."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.997161\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T05:18:20Z","timestamp":1668575900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.997161\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,16]]},"references-count":21,"alternative-id":["10.3389\/fmed.2022.997161"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.997161","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,11,16]]},"article-number":"997161"}}